Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian C Baumann

Showing results (31-40 of 104) with videos related to

Pageof 11
Sort By:
Brachytherapy|February 6, 2022
Assessing the role of external beam radiation therapy in combination with brachytherapy versus brachytherapy alone for unfavorable intermediate-risk prostate cancerNeal Andruska, Jeff M Michalski, Ruben Carmona, et al.
Oncotarget|January 9, 2013
Enhancing the efficacy of drug-loaded nanocarriers against brain tumors by targeted radiation therapyBrian C Baumann, Gary D Kao, Abdullah Mahmud, et al.
The Journal of Urology|August 27, 2017
Treatment Patterns and Overall Survival Outcomes of Octogenarians with Muscle Invasive Cancer of the Bladder: An Analysis of the National Cancer DatabaseBenjamin W Fischer-Valuck, Yuan James Rao, Soumon Rudra, et al.
Practical Radiation Oncology|June 18, 2022
Lutetium-177 Prostate-Specific Membrane Antigen Therapy: A Practical ReviewAngela Y Jia, Rojano Kashani, Nicholas G Zaorsky, et al.
Practical Radiation Oncology|June 12, 2022
International Consensus Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical Cystectomy: Update From an IBIS WorkgroupFlor Verghote, Paul Sargos, John P Christodouleas, et al.
European Urology Focus|September 19, 2017
Treatment Patterns and Survival Outcomes for Patients with Small Cell Carcinoma of the BladderBenjamin W Fischer-Valuck, Yuan James Rao, Lauren E Henke, et al.
Cancer|October 28, 2016
Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710Eric Ojerholm, Andrew Smith, Wei-Ting Hwang, et al.
Journal of Applied Clinical Medical Physics|January 13, 2023
Logistical, technical, and radiation safety aspects of establishing a radiopharmaceutical therapy program: A case in Lutetium-177 prostate-specific membrane antigen (PSMA) therapyJacqueline E Zoberi, Jose Garcia-Ramirez, David Luechtefeld, et al.
Clinical Genitourinary Cancer|January 28, 2022
Propensity-Weighted Survival Analysis of SBRT vs. Conventional Radiotherapy in Unfavorable Intermediate-Risk Prostate CancerNeal Andruska, Benjamin W Fischer-Valuck, Temitope Agabalogun, et al.
Frontiers in Oncology|October 17, 2019
Abscopal Effect Following Proton Beam Radiotherapy in a Patient With Inoperable Metastatic Retroperitoneal SarcomaRandall J Brenneman, Nima Sharifai, Benjamin Fischer-Valuck, et al.
Pageof 11

Showing results (31-40 of 104) with videos related to

Sort By:
Pageof 11
Brachytherapy|February 6, 2022
Assessing the role of external beam radiation therapy in combination with brachytherapy versus brachytherapy alone for unfavorable intermediate-risk prostate cancerNeal Andruska, Jeff M Michalski, Ruben Carmona, et al.
Oncotarget|January 9, 2013
Enhancing the efficacy of drug-loaded nanocarriers against brain tumors by targeted radiation therapyBrian C Baumann, Gary D Kao, Abdullah Mahmud, et al.
The Journal of Urology|August 27, 2017
Treatment Patterns and Overall Survival Outcomes of Octogenarians with Muscle Invasive Cancer of the Bladder: An Analysis of the National Cancer DatabaseBenjamin W Fischer-Valuck, Yuan James Rao, Soumon Rudra, et al.
Practical Radiation Oncology|June 18, 2022
Lutetium-177 Prostate-Specific Membrane Antigen Therapy: A Practical ReviewAngela Y Jia, Rojano Kashani, Nicholas G Zaorsky, et al.
Practical Radiation Oncology|June 12, 2022
International Consensus Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical Cystectomy: Update From an IBIS WorkgroupFlor Verghote, Paul Sargos, John P Christodouleas, et al.
European Urology Focus|September 19, 2017
Treatment Patterns and Survival Outcomes for Patients with Small Cell Carcinoma of the BladderBenjamin W Fischer-Valuck, Yuan James Rao, Lauren E Henke, et al.
Cancer|October 28, 2016
Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710Eric Ojerholm, Andrew Smith, Wei-Ting Hwang, et al.
Journal of Applied Clinical Medical Physics|January 13, 2023
Logistical, technical, and radiation safety aspects of establishing a radiopharmaceutical therapy program: A case in Lutetium-177 prostate-specific membrane antigen (PSMA) therapyJacqueline E Zoberi, Jose Garcia-Ramirez, David Luechtefeld, et al.
Clinical Genitourinary Cancer|January 28, 2022
Propensity-Weighted Survival Analysis of SBRT vs. Conventional Radiotherapy in Unfavorable Intermediate-Risk Prostate CancerNeal Andruska, Benjamin W Fischer-Valuck, Temitope Agabalogun, et al.
Frontiers in Oncology|October 17, 2019
Abscopal Effect Following Proton Beam Radiotherapy in a Patient With Inoperable Metastatic Retroperitoneal SarcomaRandall J Brenneman, Nima Sharifai, Benjamin Fischer-Valuck, et al.
Pageof 11